Bibliographic citations
Quispe, M., (2024). Prevalencia de esteatosis simple y esteatohepatitis no alcohólica en pacientes obesos y valoración de variables clínicas y bioquímicas asociadas [Universidad Peruana Cayetano Heredia]. https://hdl.handle.net/20.500.12866/16264
Quispe, M., Prevalencia de esteatosis simple y esteatohepatitis no alcohólica en pacientes obesos y valoración de variables clínicas y bioquímicas asociadas []. PE: Universidad Peruana Cayetano Heredia; 2024. https://hdl.handle.net/20.500.12866/16264
@misc{renati/1281873,
title = "Prevalencia de esteatosis simple y esteatohepatitis no alcohólica en pacientes obesos y valoración de variables clínicas y bioquímicas asociadas",
author = "Quispe Arminta, Marcela Cecilia",
publisher = "Universidad Peruana Cayetano Heredia",
year = "2024"
}
Background: The increasing prevalence of obesity in Peru increases the number of patients with steatotic liver disease and consequently its associated complications and comorbidities such as cirrhosis and cancer. However, it is unknown what percentage of obese patients have fatty liver. Objective: to determine the prevalence of hepatic steatosis (NAFLD), non-alcoholic steatohepatitis (NASH) and describe the clinical and biochemical characteristics in obese patients with liver biopsy from a private clinic in Lima. Materials and methods: Descriptive, retrospective cross-sectional study. The medical records of obese patients undergoing bariatric surgery who had a liver biopsy taken intraoperatively were reviewed. The information was collected using a data collection form and said data was entered into a database in Excel Office. Subsequently, statistical analysis was performed in SPSS Statistics 23. Results: Of a total of 203 obese patients, the prevalence of patients without fatty liver was 8.37%; with simple steatosis (NAFL), 13.31%; with NASH, 78.32%; and if we consider only the population with NAFLD, 85.48% had NASH. Hypertriglyceridemia and diabetes mellitus were significantly higher in obese people with hepatic steatosis vs. obese people without steatosis. While when comparing the group of obese people with simple hepatic steatosis Vs obese people with NASH, only age and basal glucose presented a significant difference. Conclusion: In Peruvian obese patients with a liver biopsy study, the prevalence of NAFLD was 91.63%; from simple steatosis it was 13.31% and from NASH it was 78.32%.
This item is licensed under a Creative Commons License